Weekly Wrap: Our Take on Dividend-Growth Stocks, RMD Rules, and Student Loans
We recap the week on Morningstar.com and note the most popular stocks, funds, and exchange-traded funds.
|Editor's note: Read the latest on how the coronavirus is rattling the markets and what investors can do to navigate it.|
5 Undervalued Dividend-Growth Stocks
These heavily weighted names in the Morningstar US Dividend Growth Index are all at least 10% undervalued.
Required Minimum Distributions: Why All the Tinkering?
Congress continues to change the RMD rules, but contributor Mark Miller argues the activity isn't improving retirement security.
2 Dividend ETFs for an IRA
These picks from Vanguard and Schwab make the most of this tax-friendly wrapper.
Digging Into Ark Innovation's Portfolio
We reveal how the ultra-popular fund's underlying holdings stack up on 11 measures of equity-related risk.
One Year Later: Lessons Learned From the 2020 Bear Market
The biggest takeaway from that period is not to panic when the market tumbles.
5 Questions About Student Loan Forgiveness
We take a closer look at the numbers to determine the impact of canceling student loans at different levels on both individual households and the larger economy.
Portfolio Planning and Personal Finance With Christine Benz
100 Must-Know Statistics About Race, Income, and Wealth
Income and wealth disparities along racial lines have repercussions for all aspects of life in the U.S.: education, health, homeownership, retirement, and life expectancy.
Mutual Funds and Exchange-Traded Funds
Inside a Tough Year for Primecap
One of my favorite Vanguard fund managers fell well behind in 2020.
Manager Question of the Month: On the Road Again?
Stock fund managers mull the value of post-pandemic travel.
The Case for Indexing in the Corporate Bond Market
Low fees and market-representative portfolios make corporate bond ETFs a compelling option.
American Funds Target Retirement Delivers, on Its Own Terms
American Funds has blazed its own trail to chart-topping results. But can it change course if the tide shifts?
A New Frontier in Cancer Screening and Treatment
If liquid biopsy lives up to its potential, a paradigm shift in cancer detection is possible.
Can Bumble Compete?
The dating app operator has gotten a lot of buzz for its CEO, the youngest female leader of a public company in the U.S., yet it enters a potentially crowded market with its 'freemium' model.
3 New Stocks to Consider
Morningstar recently added a few companies to its coverage list. Here's what our analysts think of the newcomers.
Walmart: Soft End to Year Doesn't Alter Long-Term View
We suggest investors await a more attractive entry point.
What to Know: Indexed Annuities
Lower risk has a high price.
Cultural Competency: How Advisors Can Educate Themselves on the Immigrant Experience
Here are ways financial advisors can better understand clients' culture to bring about better advice.
The Long View Podcast
Russel Kinnel: 'Fear and Greed Are the Enemy of Good Investing'
Morningstar’s director of manager research on 'Flowmageddon,' seismic shifts in the fund industry, and why fund-company mergers usually fizzle.
2020's Trends in U.S. Fund Flows Persist Into 2021
Investor appetites were largely unchanged, but a few themes emerged in January.
What Unchecked Short-Selling Means for the Stock Market
As the CEOs of Reddit and Robinhood testify before Congress, we look at the impact events like the GameStop stock saga have on the market.
Should I Buy Apple Stock Now?
What you have to believe to justify the high valuation that the market is placing on Apple's stock.